SLC5A2 and neoplasm: In addition, the new technologies described above, which allow selective accumulation of canagliflozin within the tumour and thus increase the effectiveness of the anticancer action of canagliflozin, especially in combination with radiotherapy, is a significant step forward on the way towards the effective and safe use of SGLT-2 inhibitors in oncology.